Cargando…
Erratum: SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
Autores principales: | Berzaghi, R., Maia, V. S. C., Pereira, F. V., Melo, F. M., Guedes, M. S., Origassa, C. S. T., Scutti, J. B., Matsuo, A. L., Câmara, N. O. S., Rodrigues, E. G., Travassos, L. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318987/ https://www.ncbi.nlm.nih.gov/pubmed/28220798 http://dx.doi.org/10.1038/srep42827 |
Ejemplares similares
-
SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
por: Berzaghi, R., et al.
Publicado: (2017) -
Erratum: PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice
Publicado: (2021) -
Erratum to “Endoscopic Spine Surgery” by Choi G, et al. (J Korean Neurosurg Soc 60 : 485-497, 2017)
Publicado: (2019) -
The Significance of Rectus Femoris for the Favorable Functional Outcome After Total Femur Replacement: Erratum
Publicado: (2016) -
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer(1)
Publicado: (2020)